PharmaLegacy Research LLC, dba. BTS Research Announces Expansion of their Headquarters & In Vitro Labs in their New San Diego Facility
PharmaLegacy Research LLC, dba. BTS Research Announces Expansion of their Headquarters & In Vitro Labs in their New San Diego Facility San Diego, CA
February 1, 2025 San Diego, California —
BTS Research, a leading provider of in vitro and in vivo preclinical drug development services, announces the expansion of its San Diego operations.
The move, from nearly 4,000 SF facility at 9990 Mesa Rim Road, Suite 100, to over 12,000 SF at 6042 Cornerstone Court West, Suite E, San Diego, CA 92121 represents a substantial increase in operational capacity to accommodate its growing operations following its recent acquisition by Pharmalegacy Research LLC, a San Diego-based preclinical contract research organization (CRO).
Enhanced Capabilities and Services
The relocation and expansion will allow BTS Research to broaden its service offerings and improve operational efficiency. The larger laboratory space will house advanced equipment for in vitro, histopathology and bioanalytical services, enabling the company to meet the growing demands of its clients in the pharmaceutical, biopharmaceutical, and biotechnology sectors.
Key Features of the New Facility:
- In Vitro Research Capabilities: Cell-based assays, biochemical studies, and molecular biology research.
- Histopathology Services: A dedicated area for tissue processing, staining, and microscopic analysis.
- Bioanalytical Services: Pharmacokinetics (PK/TK), pharmacodynamics (PD), Immunogenicity (ADA, Nab) and metabolites; Non-regulated bioanalysis and GLP bioanalysis; Cutting-edge platforms including LC-MS/MS, PCR, MSD, and flow cytometry.
- GLP-Compliant Facilities: Designed to meet and exceed Good Laboratory Practice standards.
- Service Drug Modalities: Small molecules, peptides and oligonucleotides; Cell and gene therapies; Antibody-drug conjugates (ADCs); Proteolysis-targeting chimeras
Commitment to Excellence
BTS Research, with roots dating back to 2001, has built a strong reputation for reliability, quality, and timely delivery of preclinical studies. The new facility will further strengthen the company's ability to conduct cutting-edge research in areas such as pharmacology, toxicology, and drug metabolism.
The relocation is scheduled to be completed by March 1, 2025, with no anticipated disruption to ongoing client projects. BTS Research will continue to operate under full compliance with GLP regulations and maintain its commitment to the highest standards of animal care and scientific integrity.
For more information about BTS Research and its services, please visit www.btsresearch.com or contact:
BTS Research
6042 Cornerstone Court West, Suite E
San Diego, CA 92121
Phone: (858) 605-5882
Email: info@btsresearch.com
About BTS Research:
BTS Research is a San Diego-based preclinical CRO that delivers GLP and Non-GLP biological services to clients in pharmaceutical, biopharmaceutical, biotech, academic research, medical device, and related industries with an extensive track record of conducting 1000’s of studies and 100’s of IND enabling studies with roots dating back to 2001 when they acquired Bio-Quant in 2011.
‘For more information on BTS Research, visit https://btsresearch.com/